-
The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains
Post on 2/22/21
-
Did Merck Make a Mistake With a Key FDA Filing?
Post on 2/22/21
-
Citius Pharmaceuticals Closes $76.5M Registered Direct Offering
Post on 2/21/21
-
AIkido Pharma Closes of $75 Million Bought Deal Offering of Common Stock
Post on 2/19/21
-
Pfizer and BioNTech Launch Coronavirus Vaccine Study for Pregnant Women
Post on 2/19/21
-
Medicus Sciences Acquisition Corp. Closes $92M IPO
Post on 2/18/21
-
Talk To Your Doc About Cancer Screenings!
Post on 2/18/21
-
Safest States During COVID-19 – Updated WalletHub Study
Post on 2/18/21
-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results
Post on 2/18/21
-
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
Post on 2/18/21
-
Citius Pharmaceuticals Prices $76.5 Million Registered Direct Offering
Post on 2/17/21
-
Caladrius Biosciences Closes $65 Million Registered Direct Offerings
Post on 2/17/21
-
ICV Partners Majority Investment in Total Access Urgent Care
Post on 2/17/21
-
AIkido Pharma Announces $10 Million Bought Deal Offering Of Common Stock
Post on 2/17/21
-
Citybiz Interview with Jim Rogers, CEO HealthConnect Networks and Mission Broadband
Post on 2/19/21
-
Cedar Partners With Summit CityMD to Offer a New, Patient-Forward Financial Experience
Post on 2/17/21
-
Royalty Pharma Reports Q4 2020 and Full-Year Results
Post on 2/17/21
-
Galmed Pharmaceuticals Prices of $10 Million Public Offering of Ordinary Shares
Post on 2/16/21
-
Zoetis Reports Fourth Quarter and Full Year 2020 Results
Post on 2/16/21
-
IQVIA Offers of Senior Notes
Post on 2/16/21
-
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
Post on 2/16/21
-
GBS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Post on 2/16/21
-
Hepion Pharmaceuticals Prices of Public Offering
Post on 2/16/21
-
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Post on 2/16/21
-
What's the Outlook for Pfizer Stock?
Post on 2/16/21
New York
